LEO Pharma is a global pharmaceutical company dedicated to developing treatments and solutions that deliver value to patients and societies all around the world.
CancerClotTM is funded and developed by LEO Pharma.
LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin and thrombotic conditions. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology and thrombosis.
We are dedicated to advancing the care of people with thrombosis. Our goal is to improve the quality of live for people living with cancer associated thrombosis (CAT)
For more information please visit www.leo-pharma.co.uk